Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo J van de Berg

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Opinion in Immunology|April 29, 2008
Cytotoxic human CD4(+) T cellsPablo J van de Berg, Ester M van Leeuwen, Ineke J ten Berge, et al.
Leukemia & Lymphoma|March 9, 2012
Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemiaSanne H Tonino, Pablo J van de Berg, Si La Yong, et al.
The Journal of Infectious Diseases|July 17, 2010
Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signaturePablo J van de Berg, Kirstin M Heutinck, Robin Raabe, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Opinion in Immunology|April 29, 2008
Cytotoxic human CD4(+) T cellsPablo J van de Berg, Ester M van Leeuwen, Ineke J ten Berge, et al.
Leukemia & Lymphoma|March 9, 2012
Expansion of effector T cells associated with decreased PD-1 expression in patients with indolent B cell lymphomas and chronic lymphocytic leukemiaSanne H Tonino, Pablo J van de Berg, Si La Yong, et al.
The Journal of Infectious Diseases|July 17, 2010
Human cytomegalovirus induces systemic immune activation characterized by a type 1 cytokine signaturePablo J van de Berg, Kirstin M Heutinck, Robin Raabe, et al.
Pageof 1